Udgivet1 gang : 18/03/2017 – 01:59
- Results to be Presented as Late-Breaking Oral Presentation
– Largest International Trial Conducted in Multiple Myeloma
– Study Met Primary Endpoint of Non-Inferiority Versus Zoledronic Acid in Delaying Bone Complications Known as Skeletal-Related Events